DARWIN EU® - Drug Utilisation Study on Antibiotics in the ‘Reserve’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation
• Data collection methods:
  Secondary use of data

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Name of medicine, other:
  All antibiotics listed under the WHO AWaRe ‘Reserve’ category 2023

Population studied

Study design details

• Main study objective:
  1. To investigate the incidence of use of antibiotics (from the WHO AWaRe Reserve category) stratified by age, sex, calendar year/month, and antibiotics class during the study period 2012-2024.; 2. To characterise antibiotic (WHO AWaRe ‘Reserve’ category 2023) use by duration of use over the study period 2012 to 2024 stratified by calendar year and by antibiotics class.; 3. To characterise antibiotic use (WHO AWaRe Reserve list 2023) by indication of use over the period 2012 to 2024 stratified by calendar year and by antibiotics class. ;